Autosomal dominant polycystic kidney disease in children

Area of Science:

• Nephrology
• Genetics
• Pediatrics

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease, affecting 1 in 500 individuals.
• Characterized by progressive renal tubule dilation and kidney enlargement, ADPKD often leads to end-stage renal disease by age 60.
• While historically considered an adult condition, ADPKD significantly impacts children and young adults, necessitating early recognition and management.

Purpose of the Study:

• To review the clinical manifestations, diagnosis, and management of ADPKD in pediatric populations.
• To highlight the importance of early interventions for improved long-term outcomes in ADPKD.
• To discuss recent clinical trials focusing on disease-specific therapies for ADPKD in children and adults.

Main Methods:

• Literature review of clinical manifestations, diagnosis, and management strategies for ADPKD in childhood.
• Analysis of recent clinical trials in pediatric and adult ADPKD cohorts.
• Synthesis of current understanding regarding early-life interventions and disease-specific therapies.

Main Results:

• ADPKD complications are increasingly recognized in pediatric and young adult populations.
• Early interventions are essential for optimizing long-term outcomes in ADPKD.
• Recent clinical trials are shifting ADPKD management towards disease-specific therapies, moving beyond general chronic kidney disease principles.

Conclusions:

• Pediatricians must be adept at recognizing ADPKD manifestations and complications.
• Timely diagnosis and appropriate management, including disease-specific therapies, are critical for pediatric ADPKD patients.
• Ongoing research and clinical trials are vital for advancing ADPKD care in all age groups.